Vanguard European Stock Index Fund Investor Shares (VEURX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
38.85
+0.14 (0.36%)
Apr 25, 2025, 4:00 PM EDT
9.41% (1Y)
Fund Assets | 19.55B |
Expense Ratio | 0.24% |
Min. Investment | $3,000 |
Turnover | n/a |
Dividend (ttm) | 1.13 |
Dividend Yield | 2.92% |
Dividend Growth | 0.81% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 21, 2025 |
Previous Close | 38.71 |
YTD Return | 14.08% |
1-Year Return | 12.91% |
5-Year Return | 87.82% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 1260 |
Inception Date | Jun 18, 1990 |
About VEURX
The Vanguard European Stock Index Fund Investor Shares (VEURX) seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe. VEURX employs an indexing investment approach by investing all of its assets in the common stocks included in the FTSE Developed Europe All Cap Index.
Fund Family Vanguard
Category Europe Stock
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol VEURX
Share Class Investor Shares
Index FTSE Developed Europe All Cap Net Tax (US RIC) TR
Performance
VEURX had a total return of 12.91% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.06%.
Top 10 Holdings
17.95% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 2.30% |
Nestlé S.A. | NESN | 2.04% |
ASML Holding N.V. | ASML | 2.01% |
Roche Holding AG | ROG | 1.77% |
Shell plc | SHEL | 1.74% |
AstraZeneca PLC | AZN | 1.72% |
Novartis AG | NOVN | 1.72% |
Novo Nordisk A/S | NOVO.B | 1.72% |
HSBC Holdings plc | HSBA | 1.59% |
Siemens Aktiengesellschaft | SIE | 1.34% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 21, 2025 | $0.1432 | Mar 24, 2025 |
Dec 20, 2024 | $0.3727 | Dec 23, 2024 |
Sep 20, 2024 | $0.0777 | Sep 23, 2024 |
Jun 21, 2024 | $0.540 | Jun 24, 2024 |
Mar 15, 2024 | $0.1854 | Mar 18, 2024 |
Dec 15, 2023 | $0.2336 | Dec 18, 2023 |